Showing results (1-10 of 9) with videos related to
Sort By:
Pageof 1
ACS Chemical Neuroscience|September 29, 2012
Total synthesis and biological evaluation of phidianidines A and B uncovers unique pharmacological profiles at CNS targetsJohn T Brogan, Sydney L Stoops, Craig W LindsleyExpert Opinion on Therapeutic Patents|June 4, 2011
Inhibition of Akt with small molecules and biologics: historical perspective and current status of the patent landscapeMargrith E Mattmann, Sydney L Stoops, Craig W LindsleyBioorganic & Medicinal Chemistry Letters|July 27, 2010
Total synthesis and biological evaluation of tambjamine K and a library of unnatural analogsLeslie N Aldrich, Sydney L Stoops, Brenda C Crews, et al.ACS Chemical Neuroscience|January 17, 2012
Total Synthesis (+)-7-Bromotrypargine and Unnatural Analogs: Biological Evaluation Uncovers Activity at CNS Targets of Therapeutic RelevanceJohn T Brogan, Sydney L Stoops, Brenda C Crews, et al.Bioorganic & Medicinal Chemistry Letters|August 25, 2015
Optimization of a small molecule probe that restores e-cadherin expressionJohn T Brogan, Sydney L Stoops, Suzanne Brady, et al.Cell Chemical Biology|May 18, 2016
Discovery of Phosphorylated Peripherin as a Major Humoral Autoantigen in Type 1 Diabetes MellitusTodd M Doran, Jumpei Morimoto, Scott Simanski, et al.Oncotarget|June 18, 2015
Small molecule/ML327 mediated transcriptional de-repression of E-cadherin and inhibition of epithelial-to-mesenchymal transitionHanbing An, Sydney L Stoops, Natasha G Deane, et al.ACS Chemical Biology|January 19, 2011
Identification and optimization of small molecules that restore E-cadherin expression and reduce invasion in colorectal carcinoma cellsSydney L Stoops, A Scott Pearson, Connie Weaver, et al.Bioorganic & Medicinal Chemistry Letters|March 10, 2009
Design and synthesis of isoform-selective phospholipase D (PLD) inhibitors. Part I: Impact of alternative halogenated privileged structures for PLD1 specificityJana A Lewis, Sarah A Scott, Robert Lavieri, et al.Pageof 1